By working with the world’s leading microbiome research institute in APC, we look forward to providing critical health offerings for key unmet needs around maternal and infant health as well as solutions for cognitive health and well-being.
WILMINGTON, Del. (PRWEB) March 12, 2020
Today, DuPont Nutrition & Biosciences (DuPont) announced a second collaboration with the APC Microbiome Ireland SFI Research Center (APC), a pioneer in the field of microbiome science, which focuses on microbes that live in and on the body and play a significant role in human health, based at University College Cork and Teagasc Moorepark.
Representatives from both organizations attended an event Washington D.C., to celebrate U.S.-Ireland research and development collaborations, and to announce the ‘Missing Microbes in Infants born by C-section’ (MiMIC) project and its potential to improve infant health. The €6.3 million, four-year project will be funded jointly by DuPont and Science Foundation Ireland’s Spokes program, a platform that is designed to deliver excellent research results and discoveries with industrial relevance to bring significant economic and societal impact.
Martin J. Kullen, Ph.D., Director of Probiotics and Microbiome Research at DuPont Nutrition & Biosciences said, “We are honored and privileged to be working with APC with the help of funding from Science Foundation Ireland on solutions and products that are key to our human microbiome platform. By working with the world’s leading microbiome research institute in APC, we look forward to providing critical health offerings for key unmet needs around maternal and infant health as well as solutions for cognitive health and well-being.”
The DuPont Human Microbiome Venture (HMV) was launched in 2017 to spearhead the development of next-generation microbiome solutions for improved health and wellness. Staying at the forefront of biotechnology innovation, HMV is designed to accelerate product development to complement its existing portfolio and build on DuPont’s strong expertise in prebiotics, microbes, proteins and enzymes.
“We are delighted to further develop our relationship with DuPont for the benefit of human health,” said APC Director Prof. Paul Ross. “APC Microbiome Ireland is a global leader, particularly in mother-infant and gut-brain areas of microbiome science, and this collaboration further strengthens our capabilities for advancing infant health and development.”
The population of bacteria in the gut develops over the first four years of life and plays a key role in human health. Establishment of a healthy gut microbiome in early life is influenced by birth mode, antibiotic use and nutrition, including breast milk components. Infant gut microbiota can be severely depleted in infants born by C-section or exposed to antibiotics. Breastfeeding can help improve microbiota composition.
APC Microbiome Ireland SFI Research Centre is ranked No. 1 globally for research in antimicrobial and therapeutic microbes and is in the top five institutions in the world for microbiome research.
“APC Microbiome Ireland has expanded the research and development capabilities of Ireland in an area of immediate relevance to the food and pharmaceutical sectors of industry,” added Prof. Catherine Stanton, Project Leader at APC Microbiome Ireland. “This project will allow us to identify the gut microbes in early life that play an important role in the short- and long-term health of individuals and will help to develop strategies to balance the microbiota following antibiotic exposure or C-section birth mode.”
Prof. Mark Ferguson, Director General of Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland said, “Science Foundation Ireland strongly welcomes this collaboration between DuPont and APC Microbiome Ireland SFI Research Centre. SFI Research Centres such as APC Microbiome Ireland are making important scientific advances, attract top research talent to Ireland, enhancing enterprise and industry, training students with critical in-demand skills, and boosting Ireland’s international reputation. We look forward to seeing the results of this industry partnership and its impact on public health.”
The Ireland-based research team also includes Prof. Eugene Dempsey, Consultant Neonatologist at Cork University Maternity Hospital and Clinical Senior Lecturer, Dept. of Pediatrics and Child Health, APC Microbiome Ireland SFI Research Centre, as well as the INFANT Research Centre (UCC) and Prof. John Cryan, who leads brain-gut-microbiome research at APC Microbiome Ireland SFI Research Centre.
About APC Microbiome Ireland
APC Microbiome Ireland SFI Research Centre (APC; http://apc.ucc.ie) explores the role that microbes (microbiome) play in health and disease. Based in University College Cork and Teagasc (the Irish Agriculture and Food Development Authority), APC Microbiome Ireland has established itself as one of the leading global centres in gut microbiota research and has made several landmark discoveries, publishing over 2,700 research articles in peer-reviewed journals. Recent research areas being led by APC Microbiome Ireland, include the development of new diagnostics or biomarkers of health or risk of disease (e.g. colon cancer) based on analysis of the microbiota; exploring the mechanisms by which the microbiota may be favorably mobilized or manipulated (e.g. by bacteriophage) to promote health and ‘mining’ the microbiota for new drugs (e.g. smart antibiotics) and functional food ingredients. Read APC’s ‘Mining Microbes for Mankind - 15 years of Impact’ report at https://apc.ucc.ie/wp-content/uploads/2015/06/APC-15-years-of-IMPACT_FINAL-WEB.pdf
About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use pioneering biotechnology to enable bio-based solutions that make products and industrial processes more efficient and sustainable. For more information: http://www.dupontnutritionandbiosciences.com or http://www.biosciences.dupont.com.
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food and worker safety. More information can be found at http://www.dupont.com.
DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.